PHARMACAPS Trademark

Trademark Overview


On Friday, April 24, 2009, a trademark application was filed for PHARMACAPS with the United States Patent and Trademark Office. The USPTO has given the PHARMACAPS trademark a serial number of 77721772. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 5, 2013. This trademark is owned by Banner Pharmacaps Inc.. The PHARMACAPS trademark is filed in the Pharmaceutical Products category with the following description:

soft gelatin and non-animal film encapsulations and hard core enrobements for various pharmaceutical preparations, namely, aids related complex (ARC) therapeutic agents, antidiarrheals, antihistamines, analgesics, antacids, antiflatulents, antifungals, antiemetics, antipyretics, antiarthritics, antiinfectives for the treatment of fungal and viral infections, antinauseants, antiobesity preparations, cancer therapy preparations, calcium supplements, cough and cold preparations, digestants, diuretics, dermatologicals for the treatment of skin disorders, hormones, histamine H2 receptor antagonists, hypnotics, hypolipidemics, laxatives, psychotherapeutics, sedatives and sleep aids; soft gelatin and non-animal film encapsulations and hard core enrobements for cardiovascular agents, namely, calcium channel blockers for heart disease; soft gelatin and non-animal film encapsulations and hard core enrobements for gastrointestinal preparations, namely, preparations for the treatment of flatulence...
pharmacaps

General Information


Serial Number77721772
Word MarkPHARMACAPS
Filing DateFriday, April 24, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 5, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 11, 2010

Trademark Statements


Goods and Servicessoft gelatin and non-animal film encapsulations and hard core enrobements for various pharmaceutical preparations, namely, aids related complex (ARC) therapeutic agents, antidiarrheals, antihistamines, analgesics, antacids, antiflatulents, antifungals, antiemetics, antipyretics, antiarthritics, antiinfectives for the treatment of fungal and viral infections, antinauseants, antiobesity preparations, cancer therapy preparations, calcium supplements, cough and cold preparations, digestants, diuretics, dermatologicals for the treatment of skin disorders, hormones, histamine H2 receptor antagonists, hypnotics, hypolipidemics, laxatives, psychotherapeutics, sedatives and sleep aids; soft gelatin and non-animal film encapsulations and hard core enrobements for cardiovascular agents, namely, calcium channel blockers for heart disease; soft gelatin and non-animal film encapsulations and hard core enrobements for gastrointestinal preparations, namely, preparations for the treatment of flatulence and constipation; soft gelatin and non-animal film encapsulations and hard core enrobements for musculoskeletal preparations, namely, calcium, vitamin D and osteoporosis treatments; soft gelatin and non-animal film encapsulations and hard core enrobements for transplant and immunosuppressant preparations, namely, cyclosporine; soft gelatin and non-animal film encapsulations and hard core enrobements for pharmaceutical preparations for the treatment of disorders of the central nervous system, the respiratory system, for the treatment of sexual dysfunction and for the treatment of neurological disorders and seizures; soft gelatin and non-animal film encapsulations and hard core enrobements for natural medicine preparations, namely, herbal supplements; soft gelatin and non-animal film encapsulations and hard core enrobements for vitamin, mineral and nutritional supplements; pharmaceutical preparations, namely, AIDS related complex (ARC) therapeutic agents, antidiarrheals, antihistamines, analgesics, antacids, antiflatulents, antifungals, antiemetics, antipyretics, antiarthritics, antiinfectives for the treatment of fungal and viral infections, antinauseants, antiobesity preparations, cancer therapy preparations, calcium supplements, cough and cold preparations, digestants, diuretics, dermatologicals for the treatment of skin disorders, hormones, histamine H2 receptor antagonists, hypnotics, hypolipidemics, laxatives, psychotherapeutics, sedatives and sleep aids; cardiovascular agents, namely, calcium channel blockers for heart disease; gastrointestinal products, namely, preparations for the treatment of flatulence and constipation; musculoskeletal preparations, namely, calcium, vitamin D and osteoporosis treatments; transplant and immunosuppressant preparations, namely, cyclosporine; pharmaceutical preparations for the treatment of disorders of the central nervous system, the respiratory system, for the treatment of sexual dysfunction and for the treatment of neurological disorders and seizures; natural medicine products, namely, herbal supplements; vitamin, mineral and nutritional supplements
Pseudo MarkPHARMA CAPS; PHARMACEUTICAL ENCAPSULATIONS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 28, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBanner Pharmacaps Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHigh Point, NC 27265

Party NameBanner Pharmacaps Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHigh Point, NC 27265

Trademark Events


Event DateEvent Description
Wednesday, April 30, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, August 5, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 5, 2013ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 27, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 26, 2012ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, December 26, 2012EXTENSION 5 GRANTED
Thursday, December 20, 2012EXTENSION 5 FILED
Thursday, December 20, 2012TEAS EXTENSION RECEIVED
Saturday, July 7, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 6, 2012EXTENSION 4 GRANTED
Tuesday, July 3, 2012EXTENSION 4 FILED
Tuesday, July 3, 2012TEAS EXTENSION RECEIVED
Thursday, January 12, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 11, 2012EXTENSION 3 GRANTED
Wednesday, January 4, 2012EXTENSION 3 FILED
Wednesday, January 4, 2012TEAS EXTENSION RECEIVED
Tuesday, July 12, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 11, 2011EXTENSION 2 GRANTED
Wednesday, July 6, 2011EXTENSION 2 FILED
Thursday, July 7, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 6, 2011TEAS EXTENSION RECEIVED
Thursday, January 6, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 4, 2011EXTENSION 1 GRANTED
Tuesday, January 4, 2011EXTENSION 1 FILED
Tuesday, January 4, 2011TEAS EXTENSION RECEIVED
Tuesday, July 6, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 11, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 11, 2010PUBLISHED FOR OPPOSITION
Wednesday, April 7, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 7, 2010ASSIGNED TO LIE
Saturday, March 20, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 19, 2010EXAMINER'S AMENDMENT ENTERED
Friday, March 19, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 19, 2010EXAMINERS AMENDMENT E-MAILED
Friday, March 19, 2010EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 30, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 30, 2009NON-FINAL ACTION E-MAILED
Wednesday, December 30, 2009NON-FINAL ACTION WRITTEN
Tuesday, December 1, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 1, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 1, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 23, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 23, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 23, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, July 11, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, July 11, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, July 11, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, July 11, 2009NON-FINAL ACTION E-MAILED
Saturday, July 11, 2009NON-FINAL ACTION WRITTEN
Tuesday, July 7, 2009ASSIGNED TO EXAMINER
Wednesday, April 29, 2009NOTICE OF PSEUDO MARK MAILED
Tuesday, April 28, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 28, 2009NEW APPLICATION ENTERED IN TRAM